Five cases of
rectal cancer, one male and 4 females, were preoperatively treated with
Tegafur suppositories at 1,500 mg per day, for 8 to 21 days (mean, 14 days). These
tumors were 2 early
cancers and 3 advanced
cancers, the configuration of which were one IIa type, one IIa + IIc type and 3 Borrmann 2 types. Their size ranged from 1.3 to 4.2 cm in diameter. Curative resections were performed in all cases, and the examination of the resected specimen revealed marked effects of
Tegafur as follows: 1) Reduction of
tumor size, 2) disappearance of
cancer wall, 3) degeneration of
cancer cells and destruction of
cancer glands accompanied by fibrous stroma with infiltration of lymphocytes and plasma cells, 4) formation of xanthogranulomatous tissue with foamy histiocytes, which were characteristic findings showing that
cancer tissue had been present there. As a result,
rectal cancer clearly showed remarkable response to suppository administration of
Tegafur for only about two weeks, if the
tumor cells were sensitive to the
drug.